Ayomide Atoki

Dr. Ayomide Atoki

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
SNSana Noreen
Sana Noreen
BHBushra Hashmi
Bushra Hashmi
PAPatrick Maduabuchi Aja
Patrick Maduabuchi Aja
AAAyomide Atoki
Ayomide Atoki
Fish is the primary marine source that provides adequate nutrition to the human body. Fish production is increasing every year, contributing to a sustainable economy, as they provide a significant source of income and food: This review highlights the potential health benefits, industrial applications, and toxicity of various fish species Globally, fish possess various bioactive compounds; this efficacy makes them a more edible source to consume worldwide. A wide range of bioactive compounds, primary macronutrients, micronutrients, vitamins, and minerals are present in various fish types that are essential in preventing different human disorders. The nutritional value of fish helps to provide exceptional health benefits against different human ailments. Fish are excellent sources of protein, peptides, and polyunsaturated fatty acids, particularly eicosapentaenoic acid (EPA), Alpha-linolenic acid (ALA), omega-6 fatty acids, and docosahexaenoic acid (DHA), omega-3 fatty acids that influence human health positively. Fish and their by-products are also excellent sources for developing various nutraceutical and functional foods to fight against multiple human disorders. The by-products of fish exert significant effects against infection, viral attack, cardiovascular diseases, immune disorders, oxidative stress, inflammation, neurological diseases, and other physiological complications. Few fish species are contaminated with harmful substances that cause potential risks to children's and adults' bodies. Additionally, the therapeutic use of fish and their by-products unveils the potential nutritional benefits to reduce the burden on public health by managing dietary issues such as food security, protein deficiency, and other nutritional-related problems.

25 December 2024 in Fly
Verified
Journal Article
Open access
AAAyomide Atoki
Ayomide Atoki
PAPatrick Maduabuchi Aja
Patrick Maduabuchi Aja
TSTijjani Salihu Shinkafi
Tijjani Salihu Shinkafi
EOErick Nyakundi Ondari
Erick Nyakundi Ondari
AAAdekunle Ismahil Adeniyi
Adekunle Ismahil Adeniyi
AAAkinpelumi Akin-Adewumi
Akinpelumi Akin-Adewumi
Drosophila melanogaster is a highly versatile model organism that has profoundly advanced our understanding of human diseases. With more than 60% of its genes having human homologs, Drosophila provides an invaluable system for modelling a wide range of pathologies, including neurodegenerative disorders, cancer, metabolic diseases, as well as cardiac and muscular conditions. This review highlights key developments in utilizing Drosophila for disease modelling, emphasizing the genetic tools that have transformed research in this field. Technologies such as the GAL4/UAS system, RNA interference (RNAi) and CRISPR-Cas9 have enabled precise genetic manipulation, with CRISPR-Cas9 allowing for the introduction of human disease mutations into orthologous Drosophila genes. These approaches have yielded critical insights into disease mechanisms, identified novel therapeutic targets and facilitated both drug screening and toxicological studies. Articles were selected based on their relevance, impact and contribution to the field, with a particular focus on studies offering innovative perspectives on disease mechanisms or therapeutic strategies. Our findings emphasize the central role of Drosophila in studying complex human diseases, underscoring its genetic similarities to humans and its effectiveness in modelling conditions such as Alzheimer's disease, Parkinson's disease and cancer. This review reaffirms Drosophila's critical role as a model organism, highlighting its potential to drive future research and therapeutic advancements.

10 August 2023 in Nutritional Neuroscience
Verified
Journal Article
Closed access
AAAyomide Atoki
Ayomide Atoki
PAPatrick Maduabuchi Aja
Patrick Maduabuchi Aja
TSTijjani Salihu Shinkafi
Tijjani Salihu Shinkafi
EOErick Nyakundi Ondari
Erick Nyakundi Ondari
CAChinaza Godswill Awuchi
Chinaza Godswill Awuchi
According to epidemiological research, as the population ages, neurological illnesses are becoming a bigger issue. Despite improvements in the treatment of these diseases, there are still widespread worries about how to find a long-lasting remedy. Several neurological diseases can be successfully treated with natural substances. As a result, current research has been concentrated on finding effective neuroprotective drugs with improved efficacy and fewer side effects. Naringenin is one potential treatment for neurodegenerative diseases. Many citrus fruits, tomatoes, bergamots, and other fruits are rich in naringenin, a flavonoid. This phytochemical is linked to a variety of biological functions. Naringenin has attracted a lot of interest for its ability to exhibit neuroprotection through several mechanisms. In the current article, we present evidence from the literature that naringenin reduces neurotoxicity and oxidative stress in brain tissues. Also, the literatures that are currently accessible shows that naringenin reduces neuroinflammation and other neurological anomalies. Additionally, we found several studies that touted naringenin as a promising anti-amyloidogenic, antidepressant, and neurotrophic treatment option. This review's major goal is to reflect on advancements in knowledge of the molecular processes that underlie naringenin's possible neuroprotective effects. Furthermore, this article also provides highlights of Naringenin with respect to its chemistry and pharmacokinetics.

27 March 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
SNSana Noreen
Sana Noreen
BHBushra Hashmi
Bushra Hashmi
PAPatrick Maduabuchi Aja
Patrick Maduabuchi Aja
AAAyomide Atoki
Ayomide Atoki
\N\R\Nsana Noreen
\R\Nsana Noreen
Introduction: Pomegranate (Punica granatum L.) is a fruit native to South Asia and currently can grow in tropical and subtropical areas, which produces approximately seven thousand metric tons per year. Pomegranate stands out for its rich flavor and functional properties, which is why it has gained acceptance in different countries. Beyond its health advantages, it has industrial applications in food technology, cosmetics, and medicines. This study focuses on its diverse phytochemical profile and the medicinal properties of its bioactive components.Methods: A search in PubMed, Scopus, EBSCO, Medline, PubMed, Embase, SID, and Iran Medex databases was conducted to identify clinical and observational studies on Pomegranate consumption and its industrial uses.Results: Pomegranate and its by-products are rich in beneficial phytochemicals, provide health benefits, and help manage ailments. Sustainable reuse of its by-products supports health, economic growth, and food security.Conclusion: Pomegranate provide health benefits, including antidiabetic, antioxidant, anticancer, and anti-inflammatory effects, with potential for food product development and disease management. Analyzing pomegranate's functional and nutritional properties, especially its peel and seed, is crucial for understanding the mechanisms involved in industrial processes for nutraceutical or functional food products.

20 July 2023 in International Journal of Food Properties
Verified
Journal Article
Open access
AAAyomide Atoki
Ayomide Atoki
PAPatrick Maduabuchi Aja
Patrick Maduabuchi Aja
TSTijjani Salihu Shinkafi
Tijjani Salihu Shinkafi
EOErick Nyakundi Ondari
Erick Nyakundi Ondari
CAChinaza Godswill Awuchi
Chinaza Godswill Awuchi

12 May 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
IIIzwa Ishaq
Izwa Ishaq
SNSANA NOREEN
SANA NOREEN
PAPatrick Maduabuchi Aja
Patrick Maduabuchi Aja
AAAyomide Atoki
Ayomide Atoki
Dietary protein is crucial in preserving muscle mass and promoting long-term bone health, particularly in aging populations. The novelty of this study lies in evaluating the impact of varying protein intake levels (0.8 vs. 1.2 g/kg b.w/d) on muscle mass composition in elderly females suffering from sarcopenia. For this purpose, in this research trial, a total of 126 participants (60–75 years) were enrolled and equally divided into two groups: normal protein intake (0.8 g/kg b.w/d) and moderately high protein intake (1.2 g/kg b.w/d) for 12 weeks. The effects of dietary protein were assessed using anthropometric measurements, magnetic resonance imaging (MRI), handgrip, and knee flexion tests with baseline and post-intervention comparisons. Statistical analysis was conducted using SPSS, employing paired sample t-test at a significance level of p < 0.05. Results indicated a significant improvement in muscle mass composition with moderately high protein intake. Anthropometric parameters, including body mass (83.51 ± 4.23 kg) and waist circumference (113.90 ± 10.82 cm), showed notable enhancement in the moderately higher protein group. Muscle function and imaging assessments, such as handgrip strength and knee flexion, demonstrated improved functionality. MRI-derived measurements of the muscle composition of the calf (141.23 ± 4.87 MCSA, mm2 × 104) and thigh (258.04 ± 7.26 MCSA, mm2 × 104) further confirmed the positive impact of increased protein intake. The study concluded that a moderately high protein diet effectively supports muscle health in elderly females with sarcopenia. Therefore, an adequate protein intake may serve as a strategic nutritional intervention to mitigate muscle loss and improve overall physical function in aging women.